Sudden unexpected death in epilepsy: A search for risk factors

2007 ◽  
Vol 10 (1) ◽  
pp. 138-141 ◽  
Author(s):  
Nikolas Hitiris ◽  
Suraya Suratman ◽  
Kevin Kelly ◽  
Linda J. Stephen ◽  
Graeme J. Sills ◽  
...  
2017 ◽  
Vol 17 (3) ◽  
pp. 180-187 ◽  
Author(s):  
Cynthia Harden ◽  
Torbjörn Tomson ◽  
David Gloss ◽  
Jeffrey Buchhalter ◽  
J. Helen Cross ◽  
...  

Objective: To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. Methods: Systematic review of evidence; modified Grading Recommendations Assessment, Development and Evaluation process for developing conclusions; recommendations developed by consensus. Results: Findings for incidence rates based on 12 Class I studies include the following: SUDEP risk in children with epilepsy (aged 0–17 years) is 0.22/1,000 patient-years (95% CI 0.16–0.31) (high confidence in evidence). SUDEP risk increases in adults to 1.2/1,000 patient-years (95% CI 0.64–2.32) (low confidence in evidence). The major risk factor for SUDEP is the occurrence of generalized tonic-clonic seizures (GTCS); the SUDEP risk increases in association with increasing frequency of GTCS occurrence (high confidence in evidence). Recommendations: Level B: Clinicians caring for young children with epilepsy should inform parents/guardians that in 1 year, SUDEP typically affects 1 in 4,500 children; therefore, 4,499 of 4,500 children will not be affected. Clinicians should inform adult patients with epilepsy that SUDEP typically affects 1 in 1,000 adults with epilepsy per year; therefore, annually 999 of 1,000 adults will not be affected. For persons with epilepsy who continue to experience GTCS, clinicians should continue to actively manage epilepsy therapies to reduce seizures and SUDEP risk while incorporating patient preferences and weighing the risks and benefits of any new approach. Clinicians should inform persons with epilepsy that seizure freedom, particularly freedom from GTCS, is strongly associated with decreased SUDEP risk.


2021 ◽  
Author(s):  
Dennis Storz ◽  
Christof Dame ◽  
Anke Wendt ◽  
Alexander Gratopp ◽  
Christoph Bührer

Sudden unexpected death in infancy (SUDI), previously termed sudden infant death syndrome (SIDS), is the second leading cause of death in infants beyond the neonatal period in Germany, and a major cause of infant mortality in economically well developed countries (OECD Health Statistics, 2019). The risk of SUDI peaks at the age of 2–4 months and then decreases continuously till the end of the first year. A complex multifactorial cause, rather than a single characteristic factor, may cause SUDI within a critical period of infant development (Guntheroth WG et al., Pediatrics 2002; 110: e64–e64). Risk factors include prematurity, male gender, bottle-feeding, prone sleeping position, overheating, as well as exposure to smoke amongst others (Carpenter RG et al., Lancet 2004; 363: 185–191). Thus, health professionals consistently advise and educate parents about avoidable risk factors of SUDI at routine well-baby examinations. Since the advent of SUDI prevention strategies in the 1980s, the incidence has decreased 10fold, from 1,55/1.000 live births in 1991 to 0,15/1000 in 2015. This number seems to have reached a steady state (Statistisches Bundesamt Germany, 2015).


2005 ◽  
Vol 65 (1-2) ◽  
pp. 101-115 ◽  
Author(s):  
José F. Téllez-Zenteno ◽  
Lizbeth Hernández Ronquillo ◽  
Samuel Wiebe

1984 ◽  
Vol 107 (6) ◽  
pp. 1300-1306 ◽  
Author(s):  
Arthur Schatzkin ◽  
Adrienne Cupples ◽  
Tim Heeren ◽  
Suzette Morelock ◽  
Marc Mucatel ◽  
...  

Seizure ◽  
2007 ◽  
Vol 16 (1) ◽  
pp. 1-7 ◽  
Author(s):  
C.P.J.A. Monté ◽  
J.B.A.M. Arends ◽  
I.Y. Tan ◽  
A.P. Aldenkamp ◽  
M. Limburg ◽  
...  

Epilepsia ◽  
2005 ◽  
Vol 46 (s11) ◽  
pp. 54-61 ◽  
Author(s):  
Torbjorn Tomson ◽  
Ted Walczak ◽  
Matti Sillanpaa ◽  
Josemir W. A. S. Sander

Sign in / Sign up

Export Citation Format

Share Document